I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Single-arm study to assess comprehensive infusion guidance ..:
Vukusic, Sandra
;
Brassat, David
;
de Seze, Jerome
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.msard.2019.01.019. , 2019
Link:
https://hal.science/hal-02566270
RT Journal T1
Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)
UL https://suche.suub.uni-bremen.de/peid=base-ftunivstetienne:oai:HAL:hal-02566270v1&Exemplar=1&LAN=DE A1 Vukusic, Sandra A1 Brassat, David A1 de Seze, Jerome A1 Izquierdo, Guillermo A1 Lysandropoulos, Andreas A1 Moll, Wibe A1 Vanopdenbosch, Ludo A1 Arque, Maria Jesus A1 Kertous, Mehdi A1 Rufi, Pascal A1 Oreja-Guevara, Celia PB HAL CCSD; Elsevier YR 2019 K1 Alemtuzumab K1 Induction therapy K1 Infusion-associated reaction (IAR) K1 Methylprednisolone treatment K1 Multiple sclerosis K1 Rash K1 MESH: Adult K1 MESH: Alemtuzumab / administration & dosage K1 MESH: Anti-Inflammatory Agents / pharmacology K1 MESH: Antibodies K1 Monoclonal K1 Humanized / administration & dosage K1 Humanized / adverse effects K1 MESH: Antipyretics / pharmacology K1 MESH: Drug Therapy K1 Combination K1 MESH: Drug-Related Side Effects and Adverse Reactions* / drug therapy K1 MESH: Drug-Related Side Effects and Adverse Reactions* / epidemiology K1 MESH: Drug-Related Side Effects and Adverse Reactions* / etiology K1 MESH: Drug-Related Side Effects and Adverse Reactions* / prevention & control K1 MESH: Exanthema* / chemically induced K1 MESH: Exanthema* / drug therapy K1 MESH: Exanthema* / epidemiology K1 MESH: Alemtuzumab / adverse effects K1 MESH: Anti-Inflammatory Agents / administration & dosage K1 [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.msard.2019.01.019 LK http://dx.doi.org/https://hal.science/hal-02566270 DO https://hal.science/hal-02566270 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)